431 related articles for article (PubMed ID: 28057794)
1. Purinergic Signaling in the Cardiovascular System.
Burnstock G
Circ Res; 2017 Jan; 120(1):207-228. PubMed ID: 28057794
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signaling and blood vessels in health and disease.
Burnstock G; Ralevic V
Pharmacol Rev; 2014; 66(1):102-92. PubMed ID: 24335194
[TBL] [Abstract][Full Text] [Related]
3. Purinergic transmission in blood vessels.
Ralevic V; Dunn WR
Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
[TBL] [Abstract][Full Text] [Related]
4. Cardiac purinergic signalling in health and disease.
Burnstock G; Pelleg A
Purinergic Signal; 2015 Mar; 11(1):1-46. PubMed ID: 25527177
[TBL] [Abstract][Full Text] [Related]
5. Purinergic Signalling and Endothelium.
Burnstock G
Curr Vasc Pharmacol; 2016; 14(2):130-45. PubMed ID: 26638799
[TBL] [Abstract][Full Text] [Related]
6. Roles of P2-purinoceptors in the cardiovascular system.
Ralevic V; Burnstock G
Circulation; 1991 Jul; 84(1):1-14. PubMed ID: 1647896
[TBL] [Abstract][Full Text] [Related]
7. Unusual absence of endothelium-dependent or -independent vasodilatation to purines or pyrimidines in the rat renal artery.
Knight GE; Oliver-Redgate R; Burnstock G
Kidney Int; 2003 Oct; 64(4):1389-97. PubMed ID: 12969158
[TBL] [Abstract][Full Text] [Related]
8. Vascular control by purines with emphasis on the coronary system.
Burnstock G
Eur Heart J; 1989 Nov; 10 Suppl F():15-21. PubMed ID: 2695333
[TBL] [Abstract][Full Text] [Related]
9. Dual control of local blood flow by purines.
Burnstock G
Ann N Y Acad Sci; 1990; 603():31-44; discussion 44-5. PubMed ID: 2291529
[TBL] [Abstract][Full Text] [Related]
10. [Involvement of nucleotide receptors in the regulation of vascular function].
Magier Z; Jarzyna R
Postepy Biochem; 2014; 60(4):456-74. PubMed ID: 25807825
[TBL] [Abstract][Full Text] [Related]
11. Blood cells: an historical account of the roles of purinergic signalling.
Burnstock G
Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710
[TBL] [Abstract][Full Text] [Related]
12. A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent.
Burnstock G; Kennedy C
Circ Res; 1986 Mar; 58(3):319-30. PubMed ID: 3013455
[TBL] [Abstract][Full Text] [Related]
13. Local control of blood pressure by purines.
Burnstock G
Blood Vessels; 1987; 24(3):156-60. PubMed ID: 3036284
[TBL] [Abstract][Full Text] [Related]
14. Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells.
Burnstock G
Pharmacol Rep; 2008; 60(1):12-20. PubMed ID: 18276981
[TBL] [Abstract][Full Text] [Related]
15. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
16. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
17. The role of adenosine triphosphate in migraine.
Burnstock G
Biomed Pharmacother; 1989; 43(10):727-36. PubMed ID: 2701287
[TBL] [Abstract][Full Text] [Related]
18. P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease.
Ralevic V
Curr Med Chem; 2015; 22(7):851-65. PubMed ID: 25515516
[TBL] [Abstract][Full Text] [Related]
19. Local mechanisms of blood flow control by perivascular nerves and endothelium.
Burnstock G
J Hypertens Suppl; 1990 Dec; 8(7):S95-106. PubMed ID: 1982771
[TBL] [Abstract][Full Text] [Related]
20. P2 receptors in cardiovascular regulation and disease.
Erlinge D; Burnstock G
Purinergic Signal; 2008 Mar; 4(1):1-20. PubMed ID: 18368530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
